Monitor for follow-up filings (8-K or 6-K) disclosing acquisition terms, financing structure, and dilution. The lack of financial detail creates ambiguity; any future revenue guidance or customer announcements from LightSolver will be critical to assess the pivot's viability.
Price Chart
Executive Summary
CollPlant completed its acquisition of LightSolver Ltd., a photonic computing company, and appointed LightSolver's founder and CEO Dr. Ruti Ben Shlomi to its board. The deal transforms CollPlant from a regenerative medicine company into a diversified deep-tech firm, but no financial terms were disclosed, and the $6M market cap company now faces the challenge of integrating and commercializing a fundamentally different technology.
Key Facts
- Acquisition of LightSolver was completed on September 3, 2026.
- Dr. Ruti Ben Shlomi, CEO and co-founder of LightSolver, appointed to CollPlant's Board of Directors.
- LightSolver's proprietary Laser Processing Unit (LPU) is an all-optical computing platform targeting high-performance computing workloads.
- No financial details of the acquisition (deal value, consideration, or terms) were provided.
- CollPlant pivots from biotech (recombinant human collagen, 3D bioprinting) into deep-tech/photonic computing.
Financial Impact
No deal value disclosed; acquisition of a pre-commercial photonic computing startup by a $6M market cap company with no reported revenue from the new segment.
Risk Factors
- Integration risk: merging a photonic computing startup into a small biotech firm with no operational overlap.
- Dilution risk: if the acquisition was funded with stock, existing holders face significant dilution given the tiny market cap.
- Execution risk: LightSolver's technology is early-stage and requires commercialization in a competitive deep-tech landscape.
- Capital needs: the combined entity may need additional financing to fund LightSolver's go-to-market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-097435 |
| Document: ea0304684-6k_collplant.htm | 0001213900-26-097435 |
| Document: 0001213900-26-097435-index-headers.html | 0001213900-26-097435 |
| Document: 0001213900-26-097435-index.html | 0001213900-26-097435 |
| Document: 0001213900-26-097435.txt | 0001213900-26-097435 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 144 | $3.78 | awaiting T+1 | — | $3.93 (+3.97%) |
Oct 19, 2026 7d ago | 3 | $3.88 $3.76 | ▼ −3.22% | ▼ −3.75% | $3.93 (+1.29%) |
Oct 15, 2026 12d ago | 6-K | $3.68 $3.63 | ▲ +1.49% | ▲ +0.39% | $3.93 (−6.79%) |
Oct 9, 2026 17d ago | 6-K | $4.02 $3.91 | ▲ +2.74% | ▲ +2.72% | $3.93 (+2.24%) |
Oct 8, 2026 19d ago | SC 13G | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.93 (−1.01%) |
Oct 8, 2026 19d ago | SC 13D/A | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.93 (−1.01%) |
Oct 6, 2026 21d ago | 6-K | $3.39 $3.46 | ▲ +2.06% | ▲ +2.30% | $3.93 (+15.93%) |
Sep 30, 2026 26d ago | 6-K | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.93 (−10.08%) |
Sep 30, 2026 26d ago | Press Release | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.93 (−10.08%) |
Sep 24, 2026 4w ago | 6-K | $4.12 $4.25 | ▲ +3.16% | ▲ +2.61% | $3.93 (−4.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers